Both in Pharmaceuticals
Edesa Biotech vs TherapeuticsMD
Over the past year EDSA returned +9.0% and TXMD returned +52.0%; their daily moves had a correlation of 0.01.
EDSA +9.0% TXMD +52.0%Growth of $1, one year, split-adjusted
| Metric | EDSA | TXMD |
|---|---|---|
| Price | $2.57 | $1.90 |
| Market cap | $24.8M | $22.0M |
| Today | −3.75% | −1.55% |
| 1 month | −37.9% | −12.8% |
| 6 months | −56.7% | −8.2% |
| Year to date | +81.0% | +16.6% |
| 1 year | +1.2% | +82.7% |
| Revenue growth (YoY) | — | −8.7% |
| Gross margin | — | 100.0% |
| Net margin | — | 17.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.7× |
| Net cash | $10.3M | $9.2M |
| Dividend yield | — | — |
| Volatility (60d) | 89.2% | 32.3% |
| Short % of float | 2.8% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).